Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study (Q38859607)

7 September 2017

title

Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study (English)

1 reference

7 September 2017

1 reference

1 reference

1 reference

7 September 2017

1 reference

7 September 2017

Martin Wolkewitz

0 references

Michael Hoffmeister

0 references

Janick Weberpals

1 reference

7 September 2017

Pauline A J Vissers

1 reference

7 September 2017

Josephina G Kuiper

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 April 2017

1 reference

International Journal of Cancer

7 September 2017

published in

1 reference

7 September 2017

volume

141

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

62-71

1 reference

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

7 September 2017

cites work

1 reference

Autonomic nerve development contributes to prostate cancer progression

21 January 2018

1 reference

Molecular pathways: beta-adrenergic signaling in cancer

21 January 2018

1 reference

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

21 January 2018

1 reference

β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy

21 January 2018

1 reference

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

21 January 2018

1 reference

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

21 January 2018

1 reference

Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis

21 January 2018

1 reference

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

21 January 2018

1 reference

β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort

21 January 2018

1 reference

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

21 January 2018

1 reference

New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System

21 January 2018

1 reference

Prevalence and determinants of pharmacy shopping behaviour

21 January 2018

1 reference

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

21 January 2018

1 reference

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

21 January 2018

1 reference

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use

21 January 2018

1 reference

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs

21 January 2018

1 reference

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

21 January 2018

1 reference

Marginal structural models and causal inference in epidemiology

21 January 2018

1 reference

Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture

21 January 2018

1 reference

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

21 January 2018

1 reference

β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.

21 January 2018

1 reference

Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.

21 January 2018

1 reference

Immortal time bias in pharmaco-epidemiology

21 January 2018

1 reference

Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.

21 January 2018

1 reference

Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage

21 January 2018

1 reference

Stage-specific associations between beta blocker use and prognosis after colorectal cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30717

1 reference

7 September 2017

1 reference